179 related articles for article (PubMed ID: 35334816)
1. Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer's Disease: Two-Year Follow-Up.
Chu CS; Hung CF; Ponnusamy VK; Chen KC; Chen NC
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334816
[TBL] [Abstract][Full Text] [Related]
2. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
[TBL] [Abstract][Full Text] [Related]
4. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy.
Tseng PT; Zeng BS; Suen MW; Wu YC; Correll CU; Zeng BY; Kuo JS; Chen YW; Chen TY; Tu YK; Lin PY; Carvalho AF; Stubbs B; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Wu MK; Shiue YL; Su KP
Brain Behav Immun; 2023 Jul; 111():352-364. PubMed ID: 37150266
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
[TBL] [Abstract][Full Text] [Related]
7. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.
Wood AHR; Chappell HF; Zulyniak MA
Eur J Nutr; 2022 Mar; 61(2):589-604. PubMed ID: 34392394
[TBL] [Abstract][Full Text] [Related]
8. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
[TBL] [Abstract][Full Text] [Related]
9. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
[TBL] [Abstract][Full Text] [Related]
10. Factors Affecting Rapid Cognitive Decline in Patients with Alzheimer's Disease: A Longitudinal Follow-Up Study.
Pan CC; Chu CS; Chen CL; Chuang YC; Chen NC
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444325
[TBL] [Abstract][Full Text] [Related]
11. Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study.
Nishihira J; Tokashiki T; Higashiuesato Y; Willcox DC; Mattek N; Shinto L; Ohya Y; Dodge HH
J Alzheimers Dis; 2016; 51(3):857-66. PubMed ID: 26890763
[TBL] [Abstract][Full Text] [Related]
12. A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
Lin PY; Chiu CC; Huang SY; Su KP
J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939
[TBL] [Abstract][Full Text] [Related]
13. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
[TBL] [Abstract][Full Text] [Related]
14. Association between serum omega-3 PUFAs levels and cognitive impairment in never medically treated first-episode patients with geriatric depression: A cross-sectional study.
Gao J; Fan H; Wang X; Cheng Y; Hao J; Han S; Wu S
J Affect Disord; 2024 Feb; 346():1-6. PubMed ID: 37923225
[TBL] [Abstract][Full Text] [Related]
15. DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK.
Vela S; Sainz N; Moreno-Aliaga MJ; Solas M; Ramirez MJ
Mol Neurobiol; 2019 Mar; 56(3):1618-1627. PubMed ID: 29911253
[TBL] [Abstract][Full Text] [Related]
16. EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.
de Souza Fernandes DP; Canaan Rezende FA; Pereira Rocha G; De Santis Filgueiras M; Silva Moreira PR; Gonçalves Alfenas Rde C
Nutr Hosp; 2015 Aug; 32(2):528-33. PubMed ID: 26268080
[TBL] [Abstract][Full Text] [Related]
17. The causal association of polyunsaturated fatty acids with allergic disease: A two-sample Mendelian randomization study.
Li Y; Li Q; Cao Z; Wu J
Front Nutr; 2022; 9():962787. PubMed ID: 36159460
[TBL] [Abstract][Full Text] [Related]
18. Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults.
de Oliveira Otto MC; Wu JHY; Thacker EL; Lai HTM; Lemaitre RN; Padhye N; Song X; King IB; Lopez O; Siscovick DS; Mozaffarian D
J Alzheimers Dis; 2023; 95(3):965-979. PubMed ID: 37638432
[TBL] [Abstract][Full Text] [Related]
19. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
Quinn JF; Raman R; Thomas RG; Yurko-Mauro K; Nelson EB; Van Dyck C; Galvin JE; Emond J; Jack CR; Weiner M; Shinto L; Aisen PS
JAMA; 2010 Nov; 304(17):1903-11. PubMed ID: 21045096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
